{
  "id": "mhgap#risk_safety_b9acb539",
  "content": "better than gabapentin in terms of seizure\neffective against all types of seizures, and hence may\nremission (HR = 1.29; 95% CI: 1.06 to 1.57), and that\nbe ASMs of choice when the type of seizure/epilepsy\ncarbamazepine has similar performance to other\nsyndrome is not clear.\nASMs, including levetiracetam and lamotrigine.\ny All ASMs are associated with adverse effects.\ny For focal onset seizures, levetiracetam and\nPhenobarbital is associated with a higher risk of\nlamotrigine perform significantly better than\nshort- and long-term tolerability problems.\ncarbamazepine in terms of adverse events (HR =\n0.56; 95% CI: 0.44 to 0.73 for lamotrigine versus y When taken during pregnancy, sodium valproate\ncarbamazepine, HR = 0.65; 95% CI: 0.47 to 0.90 is associated with a markedly higher risk of fetal\nfor levetiracetam vs carbamazepine). Given their malformations. Sodium valproate (valproic acid)\nbetter side-effect profile and similar efficacy to has also been associated with hepatic side-\ncarbamazepine, lamotrigine and levetiracetam are effects, in terms of raised transaminases and\nnow recommended for focal epilepsy. elevated ammonia levels. Sodium valproate is\ncontraindicated in individuals with liver disease.\nRemarks y Phenytoin, despite being used as a first-line drug in",
  "metadata": {
    "source": "WHO mhGAP-IG 2023",
    "url": "https://www.who.int/",
    "condition": "General",
    "risk_band": "low",
    "topics": [
      "risk_safety"
    ],
    "is_clinical": true,
    "is_advice": false
  },
  "index_text": "General â€” Risk Safety better than gabapentin in terms of seizure\neffective against all types of seizures, and hence may\nremission (HR = 1.29; 95% CI: 1.06 to 1.57), and that\nbe ASMs of choice when the type of seizure/epilepsy\ncarbamazepine has similar performance to other\nsyndrome is not clear.\nASMs, including levetiracetam and lamotrigine.\ny All ASMs are associated with adverse effects.\ny For focal onset seizures, levetiracetam and\nPhenobarbital is associated with a higher risk of\nlamotrigine perform significantly better than\nshort- and long-term tolerability problems.\ncarbamazepine in terms of adverse events (HR =\n0.56; 95% CI: 0.44 to 0.73 for lamotrigine versus y When taken during pregnancy, sodium valproate\ncarbamazepine, HR = 0.65; 95% CI: 0.47 to 0.90 is associated with a markedly higher risk of fetal\nfor levetiracetam vs carbamazepine). Given their malformations. Sodium valproate (valproic acid)\nbetter side-effect profile and similar efficacy to has also been associated with hepatic side-\ncarbamazepine, lamotrigine and levetiracetam are effects, in terms of raised transaminases and\nnow recommended for focal epilepsy. elevated ammonia levels. Sodium valproate is\ncontraindicated in individuals with liver disease.\nRemarks y Phenytoin, despite being used as a first-line drug in Better than gabapentin in terms of seizure\neffective against all types of seizures, and hence may\nremission (hr = 1.29; 95% ci: 1.06 to 1.57), and that\nbe asms of choice when the type of seizure/epilepsy\ncarbamazepine ha..."
}